Prevalence of Neurocognitive Disorder in a Pre-manifest Huntington's disease Cohort

被引:0
|
作者
Sierra, Luis [1 ]
Ullman, Clementina [1 ]
Baselga-Garriga, Clara [2 ]
Hildebrand, Karen [1 ]
Frank, Samuel [1 ]
Laganiere, Simon [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Neurol, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
关键词
D O I
10.1212/WNL.0000000000202575
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1-11.014
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Auditory mismatch negativity in pre-manifest and manifest Huntington's disease
    Delussi, Marianna
    Valt, Christian
    Silvestri, Adelchi
    Ricci, Katia
    Ladisa, Emanuella
    Ammendola, Elena
    Rampino, Antonio
    Pergola, Giulio
    de Tommaso, Marina
    CLINICAL NEUROPHYSIOLOGY, 2024, 162 : 121 - 128
  • [2] Cortical neurodevelopment in pre-manifest Huntington's disease
    Kubera, Katharina M.
    Schmitgen, Mike M.
    Hirjak, Dusan
    Wolf, Robert Christian
    Orth, Michael
    NEUROIMAGE-CLINICAL, 2019, 23
  • [3] Baseline characteristics of the PREQUEL cohort: An interventional trial in pre-manifest Huntington's disease
    Killoran, A.
    Biglan, K. M.
    Julian-Baros, E.
    Yoritomo, N.
    Ross, C. A.
    MOVEMENT DISORDERS, 2012, 27 : S57 - S57
  • [4] Dissociable Motivational Deficits in Pre-manifest Huntington's Disease
    Atkins, Kelly J.
    Andrews, Sophie C.
    Stout, Julie C.
    Chong, Trevor T-J
    CELL REPORTS MEDICINE, 2020, 1 (09)
  • [5] Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients
    Wang, Rui
    Ross, Christopher A.
    Cai, Huan
    Cong, Wei-Na
    Daimon, Caitlin M.
    Carlson, Olga D.
    Egan, Josephine M.
    Siddiqui, Sana
    Maudsley, Stuart
    Martin, Bronwen
    FRONTIERS IN PHYSIOLOGY, 2014, 5
  • [6] Cardiovascular risk factors in a pre-manifest and manifest population of Huntington's disease
    Gatto, E.
    Gonzalez Rojas, N.
    Cesarini, M.
    Etcheverry, J.
    Da Prat, G.
    MOVEMENT DISORDERS, 2020, 35 : S99 - S99
  • [7] Characterization of visual cognition in pre-manifest, manifest and reduced penetrance Huntington's disease
    Pino, Rocio Del
    Acera, Maria angeles
    de Echevarrria, Amaia Ortiz
    Tijero, Beatriz
    Ruiz-Lopez, Marta
    Somme, Johanne
    Ruiz-Martinez, Javier
    Gabilondo, Andrea
    Croitoru, Ioana M.
    Pardina, Lara
    Ayo-Mentxakatorre, Naia
    Murueta-Goyena, Ane
    Gabilondo, Inigo
    Sanchez-Pernaute, Rosario
    Fernandez-Valle, Tamara
    Esteban, Juan Carlos Gomez
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [8] Analysis of Analgesic Use in Pre-Manifest Huntington Disease
    Killoran, Annie
    Biglan, Kevin
    Julian-Baros, Elaine
    Yoritomo, Nadine
    Ross, Christopher
    NEUROLOGY, 2013, 80
  • [9] TASK-SWITCHING ABILITIES IN PRE-MANIFEST HUNTINGTON'S DISEASE SUBJECTS
    Migliore, Simone
    D'Aurizio, Giulia
    Maffi, Sabrina
    Curcio, Giuseppe
    Squitieri, Ferdinando
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A51 - A51
  • [10] CAG repeat length and weight loss in pre-manifest Huntington's disease
    Kutz, C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 574 - 574